TITLE

Perceived Impact of Diabetes Genetic Risk Testing Among Patients at High Phenotypic Risk for Type 2 Diabetes

AUTHOR(S)
MARKOWITZ, SARAH M.; PARK, ELYSE R.; DELAHANTY, LINDA M.; O'BRIEN, KELSEY E.; GRANT, RICHARD W.
PUB. DATE
March 2011
SOURCE
Diabetes Care;Mar2011, Vol. 34 Issue 3, p568
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
OBJECTIVE--Rapid advances in diabetes genetic epidemiology may lead to a new era of "personalized medicine" based on individual genetic risk assessment. There is minimal experience to guide how best to clinically implement such testing so that results (e.g., "higher" or "lower" relative genetic risk) improve rather than reduce patient motivation for behavior change. RESEARCH DESIGN AND METHODS--Between November 2009 and May 2010, we conducted in-depth interviews with 22 overweight participants at high phenotypic risk for type 2 diabetes to explore perceptions of diabetes genetic risk testing compared with currently available prediction using nongenetic risk factors (e.g., family history, abnormal fasting glucose, obesity). We used hypothetical scenarios to specifically investigate the impact of both "higher" and "lower" relative genetic risk results on participants' views about diabetes prevention RESULTS--Many participants con[erred a unique value on personal genetic risk information relative to nongenetic risk based on the perceived scientific certainty and durability of genetic results. In contrast, other participants considered their genetic risk within the overall context of their other measured risk factors. Reactions to diabetes genetic test results differed by current motivation levels. Whereas most subjects reported that "higher" risk results would motivate behavior change, subjects with lower current motivation often reported that "lower" genetic risk results would further reduce their motivation to engage in diabetes prevention behaviors. CONCLUSIONS--To be effective, future clinical implementation of type 2 diabetes genetic risk testing should be individualized based on each patient's risk perception and current level of motivation to prevent diabetes.
ACCESSION #
61791510

 

Related Articles

  • Strengthening the reporting of genetic risk prediction studies: the GRIPS statement. Janssens, A.; Ioannidis, John; Duijn, Cornelia; Little, Julian; Khoury, Muin // European Journal of Epidemiology;Apr2011, Vol. 26 Issue 4, p255 

    The rapid and continuing progress in gene discovery for complex diseases is fueling interest in the potential application of genetic risk models for clinical and public health practice. The number of studies assessing the predictive ability is steadily increasing, but the quality and...

  • Strengthening the reporting of genetic risk prediction studies (GRIPS): explanation and elaboration. Janssens, A.; Ioannidis, John; Bedrosian, Sara; Boffetta, Paolo; Dolan, Siobhan; Dowling, Nicole; Fortier, Isabel; Freedman, Andrew; Grimshaw, Jeremy; Gulcher, Jeffrey; Gwinn, Marta; Hlatky, Mark; Janes, Holly; Kraft, Peter; Melillo, Stephanie; O'Donnell, Christopher; Pencina, Michael; Ransohoff, David; Schully, Sheri; Seminara, Daniela // European Journal of Epidemiology;Apr2011, Vol. 26 Issue 4, p313 

    The rapid and continuing progress in gene discovery for complex diseases is fuelling interest in the potential application of genetic risk models for clinical and public health practice. The number of studies assessing the predictive ability is steadily increasing, but they vary widely in...

  • The Fangshan/Family-based Ischemic Stroke Study In China (FISSIC) protocol. Xun Tang; Yonghua Hu; Dafang Chen; Siyan Zhan; Zongxin Zhang; Huidong Dou // BMC Medical Genetics;2007, Vol. 8, p60 

    Background: The exact etiology of ischemic stroke remains unclear, because multiple genetic predispositions and environmental risk factors may be involved, and their interactions dictate the complexity. Family-based studies provide unique features in design, while they are currently...

  • PredictABEL: an R package for the assessment of risk prediction models. Kundu, Suman; Aulchenko, Yurii; Duijn, Cornelia; Janssens, A. // European Journal of Epidemiology;Apr2011, Vol. 26 Issue 4, p261 

    The rapid identification of genetic markers for multifactorial diseases from genome-wide association studies is fuelling interest in investigating the predictive ability and health care utility of genetic risk models. Various measures are available for the assessment of risk prediction models,...

  • Genetic epidemiology in medicine--recent twin research. Gurling, H.M.D. // British Medical Journal (Clinical Research Edition);1/7/1984, Vol. 288 Issue 6410, p3 

    Focuses on the genetic epidemiology in medicine. Studies of concordance rates in identical and fraternal twins; Implications of environmental sources on public health; Effects of smoking on health.

  • Abnormal Na-li Countertransport Kinetics in Type 1 Diabetic Patients with Nephropathy and in Their Parents. Zerbini, Gianpaolo; Maestroni, Anna; Maestroni, Silvia; Gabellini, Daniela; Luzi, Livio // Diabetes;Jun2007 Supplement 1, Vol. 56, pA91 

    An inherited predisposition to essential hypertension is presently considered the most important cause of susceptibility to nephropathy in diabetic patients. This hypothesis is confirmed by the evidence that diabetic nephropathy is characterized by an increased activity of erythrocyte Na-Li...

  • Genomic-based tools for the risk assessment, management, and prevention of type 2 diabetes. Johansen Taber, Katherine A.; Dickinson, Barry D. // Application of Clinical Genetics;2015, Vol. 8, p1 

    Type 2 diabetes (T2D) is a common and serious disorder and is a significant risk factor for the development of cardiovascular disease, neuropathy, nephropathy, retinopathy, periodontal disease, and foot ulcers and amputations. The burden of disease associated with T2D has led to an emphasis on...

  • Genetics, Big Brother and the GP. Shakespeare, Tom // British Journal of General Practice;Mar2006, Vol. 56 Issue 524, p167 

    Discusses the promotion of primary care involvement with genetics. Reason the Icelandic Medical Association refused to participate in data collection for the deCODE biobank; Discussion on the new emphasis on primary care genetic research; Key to genetic epidemiology.

  • Diabetes and Employment.  // Diabetes Care;Jan2014 Supplement, Vol. 37 Issue S1, pS112 

    The article presents guidelines for evaluating individuals with diabetes for employment. It also includes guidelines on how an assessment should be performed and what changes in the workplace may needed for an individual with diabetes. It also discusses the role of diabetes health care...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics